Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma

BackgroundClear cell renal cell carcinoma (ccRCC) remains a common malignancy in the urinary system. Although dramatic progress was made in multimodal therapies, the improvement of its prognosis continues to be unsatisfactory. The antibody-binding crystallizable fragment (Fc) γ receptors (FcγRs) are...

Full description

Bibliographic Details
Main Authors: Wenyuan Nie, Yong Yao, Benjun Luo, Jiyin Zhu, Shaocheng Li, Xiaoteng Yang, Tao Luo, Wei Liu, Shibing Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.755936/full
_version_ 1827893548413878272
author Wenyuan Nie
Yong Yao
Benjun Luo
Jiyin Zhu
Shaocheng Li
Xiaoteng Yang
Tao Luo
Wei Liu
Shibing Yan
author_facet Wenyuan Nie
Yong Yao
Benjun Luo
Jiyin Zhu
Shaocheng Li
Xiaoteng Yang
Tao Luo
Wei Liu
Shibing Yan
author_sort Wenyuan Nie
collection DOAJ
description BackgroundClear cell renal cell carcinoma (ccRCC) remains a common malignancy in the urinary system. Although dramatic progress was made in multimodal therapies, the improvement of its prognosis continues to be unsatisfactory. The antibody-binding crystallizable fragment (Fc) γ receptors (FcγRs) are expressed on the surface of leukocytes, to mediate antibody-induced cell-mediated anti-tumor responses when tumor-reactive antibodies are present. FcγRs have been studied extensively in immune cells, but rarely in cancer cells.MethodsONCOMINE, UALCAN, GEPIA, TIMER, TISIDB, Kaplan–Meier Plotter, SurvivalMeth, and STRING databases were utilized in this study.ResultsTranscriptional levels of FcγRs were upregulated in patients with ccRCC. There was a noticeable correlation between the over expressions of FCGR1A/B/C, FCGR2A, and clinical cancer stages/tumor grade in ccRCC patients. Besides, higher transcription levels of FcγRs were found to be associated with poor overall survival (OS) in ccRCC patients. Further, high DNA methylation levels of FcγRs were also observed in ccRCC patients, and higher DNA methylation levels of FcγRs were associated with shorter OS. Moreover, we also found that the expression of FcγRs was significantly correlated with immune infiltrates, namely, immune cells (NK, macrophages, Treg, cells) and immunoinhibitor (IL-10, TGFB1, and CTLA-4).ConclusionsOur study demonstrated that high DNA methylation levels of FcγRs lead to their low mRNA, protein levels, and poor prognosis in ccRCC patients, which may provide new insights into the choice of immunotherapy targets and prognostic biomarkers.
first_indexed 2024-03-12T21:55:19Z
format Article
id doaj.art-9efd4e2d53164012b2e57eeb6c88dfaf
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-12T21:55:19Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-9efd4e2d53164012b2e57eeb6c88dfaf2023-07-25T19:16:32ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-03-011210.3389/fonc.2022.755936755936Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell CarcinomaWenyuan NieYong YaoBenjun LuoJiyin ZhuShaocheng LiXiaoteng YangTao LuoWei LiuShibing YanBackgroundClear cell renal cell carcinoma (ccRCC) remains a common malignancy in the urinary system. Although dramatic progress was made in multimodal therapies, the improvement of its prognosis continues to be unsatisfactory. The antibody-binding crystallizable fragment (Fc) γ receptors (FcγRs) are expressed on the surface of leukocytes, to mediate antibody-induced cell-mediated anti-tumor responses when tumor-reactive antibodies are present. FcγRs have been studied extensively in immune cells, but rarely in cancer cells.MethodsONCOMINE, UALCAN, GEPIA, TIMER, TISIDB, Kaplan–Meier Plotter, SurvivalMeth, and STRING databases were utilized in this study.ResultsTranscriptional levels of FcγRs were upregulated in patients with ccRCC. There was a noticeable correlation between the over expressions of FCGR1A/B/C, FCGR2A, and clinical cancer stages/tumor grade in ccRCC patients. Besides, higher transcription levels of FcγRs were found to be associated with poor overall survival (OS) in ccRCC patients. Further, high DNA methylation levels of FcγRs were also observed in ccRCC patients, and higher DNA methylation levels of FcγRs were associated with shorter OS. Moreover, we also found that the expression of FcγRs was significantly correlated with immune infiltrates, namely, immune cells (NK, macrophages, Treg, cells) and immunoinhibitor (IL-10, TGFB1, and CTLA-4).ConclusionsOur study demonstrated that high DNA methylation levels of FcγRs lead to their low mRNA, protein levels, and poor prognosis in ccRCC patients, which may provide new insights into the choice of immunotherapy targets and prognostic biomarkers.https://www.frontiersin.org/articles/10.3389/fonc.2022.755936/fullclear cell renal cell carcinomaFcγ receptorprognostic valuebioinformatics analysistumor microenvironment
spellingShingle Wenyuan Nie
Yong Yao
Benjun Luo
Jiyin Zhu
Shaocheng Li
Xiaoteng Yang
Tao Luo
Wei Liu
Shibing Yan
Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma
Frontiers in Oncology
clear cell renal cell carcinoma
Fcγ receptor
prognostic value
bioinformatics analysis
tumor microenvironment
title Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma
title_full Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma
title_fullStr Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma
title_full_unstemmed Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma
title_short Systematic Analysis of the Expression and Prognosis of Fcγ Receptors in Clear Cell Renal Cell Carcinoma
title_sort systematic analysis of the expression and prognosis of fcγ receptors in clear cell renal cell carcinoma
topic clear cell renal cell carcinoma
Fcγ receptor
prognostic value
bioinformatics analysis
tumor microenvironment
url https://www.frontiersin.org/articles/10.3389/fonc.2022.755936/full
work_keys_str_mv AT wenyuannie systematicanalysisoftheexpressionandprognosisoffcgreceptorsinclearcellrenalcellcarcinoma
AT yongyao systematicanalysisoftheexpressionandprognosisoffcgreceptorsinclearcellrenalcellcarcinoma
AT benjunluo systematicanalysisoftheexpressionandprognosisoffcgreceptorsinclearcellrenalcellcarcinoma
AT jiyinzhu systematicanalysisoftheexpressionandprognosisoffcgreceptorsinclearcellrenalcellcarcinoma
AT shaochengli systematicanalysisoftheexpressionandprognosisoffcgreceptorsinclearcellrenalcellcarcinoma
AT xiaotengyang systematicanalysisoftheexpressionandprognosisoffcgreceptorsinclearcellrenalcellcarcinoma
AT taoluo systematicanalysisoftheexpressionandprognosisoffcgreceptorsinclearcellrenalcellcarcinoma
AT weiliu systematicanalysisoftheexpressionandprognosisoffcgreceptorsinclearcellrenalcellcarcinoma
AT shibingyan systematicanalysisoftheexpressionandprognosisoffcgreceptorsinclearcellrenalcellcarcinoma